Learn about ovarian cancer treatment and research at virtual patient education event
Christopher Darus, M.D., MS, gynecologic oncologist and medical director of Providence Gynecologic Oncology Program, will give an update on the latest developments in ovarian cancer diagnoses, treatments, research and clinical trials.
Virtual event details
June 29, 2022
7:00 p.m. to 8:15 p.m.
About Dr. Christopher Darus
Dr. Christopher Darus joined Providence Cancer Institute in October 2020 as medical director of Providence Gynecologic Oncology Program. He previously was director of gynecologic cancer research at Maine Medical Center in Portland, Maine.
Dr. Darus graduated from Wright State University School of Medicine in 2000 and completed his residency in Obstetrics and Gynecology at University of Colorado Health Sciences Center in 2004. Following his residency, he completed a fellowship in Gynecologic Oncology at the University of Virginia Health System in 2007. This rigorous training prepared Dr. Darus to offer advanced surgical and medical treatment techniques to his patients.
Dr. Darus has an acute understanding of the impact of a gynecologic cancer diagnosis and treatment on his patients and their families. He emphasizes the importance of treating the whole patient while utilizing the skills and strengths of the multidisciplinary team of providers at Providence Cancer Institute. His clinical interests include minimally invasive surgery, clinical trials and cancer genomics.
Dr. Darus is an avid cook and enjoys scuba diving and underwater photography. He lives in Portland with his wife and children.
Exceptional gynecologic cancer care
The Providence Gynecologic Oncology Program provides specialized care for women with suspected or known gynecologic malignancies and complex precancerous conditions. We offer care at two locations: Robert W. Franz Cancer Center at Providence Portland Medical Center and Providence St. Vincent Medical Center.
Through the program, patients have access to advanced treatments, such as robotic surgery, immunotherapy, and the latest research and clinical trials. Patients also have the convenience of receiving all their care in a single location. Learn more.